Neutrophil myeloperoxidase may strengthen healing skin by crosslinking new basement membrane
In sterile skin with insufficient peroxidasin, neutrophil myeloperoxidase may crosslink collagen IV during basement membrane assembly, shortening recovery of shear resistance. Reject this mechanism if only peroxidasin forms the crosslinks or additional crosslinks fail to improve functional recovery.
Stage of verification
- Hypothesis published2026-09-25
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Immune response
Inflammatory response
The body's inflammatory reaction to microbial or tissue-derived stimuli
Where this hypothesis actsHealing skin with insufficient peroxidasin activity and incomplete basement membrane maturation
Hypotheses on this target 4
Inhibition
Activation
Function preservation
Clearance restoration
Immunosuppression
Feedback restoration2
Rhythm restoration
What is proposed
Prolong the late neutrophil phase for a limited period
With whatNot stated in the record
HowDelay the termination of inflammation to allow neutrophil myeloperoxidase to support basement membrane maturation
Possible result
Possible shorter time to stable functional healing and resistance to shear
From the recordограниченное продление воспаления сокращает время до устойчивого функционального восстановления.
Structural protein
Collagen IV
A structural protein that forms part of the basement membrane network
Where this hypothesis actsUncrosslinked regions of the assembling basement membrane in healing skin with insufficient peroxidasin activity
Hypotheses on this target 1
Lower level
Higher level
Replacement
Protection from degradation- Function preservation
Remodelling1
Crosslink prevention
What is proposed
Remodelling
Promote maturation by forming sulfilimine crosslinks
With whatNot stated in the record
HowAllow neutrophil myeloperoxidase to access collagen IV regions before their incorporation into a dense network
Possible result
Possible stronger epidermal attachment and earlier resistance to shear
From the recordФизический носитель незавершённого состояния представляет собой несшитый коллаген IV.
Enzyme
Myeloperoxidase
A neutrophil enzyme with catalytic activity
Where this hypothesis actsLate neutrophil phase during basement membrane assembly in skin with insufficient peroxidasin activity
Hypotheses on this target 1- Inhibition1
- Activation
- Lower level
- Higher level
- Replacement
- Protection from degradation
Cofactor removal
Synthesis suppression- Function preservation
What is proposed
Inhibition
Disable catalytic activity to test its contribution to crosslink formation
With whatNot stated in the record
HowChange catalysis independently while preserving neutrophil numbers, the cytokine profile and TGF-β signal duration
Possible result
Expected loss of the crosslinking and shear-resistance benefit of the late neutrophil phase
From the recordВыключение каталитической активности миелопероксидазы устранит этот выигрыш при сохранённых числе нейтрофилов, цитокиновом профиле и длительности TGF-β-сигнала.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Skin can close over a wound before its layers are firmly attached enough to withstand rubbing or sliding forces. The unexpected move is to propose that prolonging part of the inflammatory response, the body's response to injury or infection, could shorten the wait for that strength to return. This is a hypothesis generated by the pipeline, not a measured result: it assigns a construction role to an enzyme associated with immune defense.
- Insufficient peroxidasin activity leaves newly forming collagen IV incompletely crosslinked.
- Late neutrophils supply myeloperoxidase while unfinished collagen IV remains accessible.
- Myeloperoxidase is proposed to form sulfilimine crosslinks before the basement membrane finishes assembling.
- Those bonds are proposed to turn a closed but weakly attached skin surface into one that resists sliding forces.
- Keeping inflammation active through that construction window is proposed to shorten the total time to durable functional recovery.
A newly laid floor may look finished while the glue underneath is still setting. Closing the room's repair work too soon could leave a surface that shifts when people walk across it.
Where the picture breaks: The analogy explains the difference between surface closure and firm attachment. It does not establish that myeloperoxidase can make the required bonds, or that keeping inflammation active would help more than it harms.
- Master questionstep 01 of 04
A therapy is sought that would bring the functional condition of middle-aged human skin closer to that of young people.
Rests on: The goal defines younger skin function as the desired outcome, but supplies neither a particular treatment nor a measurement of that outcome.
Stated in the chain - Goal pillarstep 02 of 04
Protection, wound repair and the return to physical loading need to be coordinated in time.
Rests on: The broader goal concerns skin function; this stage selects the timing of repair and renewed loading as a route toward that goal.
AssumptionIt assumes that improving the coordination of wound repair and return to loading would advance the stated goal of restoring youthful function in middle-aged skin. The goal itself does not establish that connection.
- Gap questionstep 03 of 04
Allowing inflammation to finish later might make skin function recover sooner if the stopping point depends on remaining microbes and the maturity of the matrix, the supporting material surrounding cells.
Rests on: The preceding stage explicitly calls for coordinating protection, healing and return to loading. This question develops that timing problem into a possible tradeoff between ending inflammation and completing repair.
Stated in the chain - Hypothesisstep 04 of 04
Late-arriving neutrophils, immune cells involved in defense, are proposed to help finish the basement membrane, the thin supporting layer beneath the epidermis, the skin's outer layer. Their enzyme myeloperoxidase is proposed to reach unfinished collagen IV, a protein that forms a supporting network, and make sulfilimine crosslinks, chemical bonds joining parts of that network. When peroxidasin, an enzyme associated with collagen IV crosslinking, has insufficient activity, this temporary route is proposed to become necessary for firm attachment of the outer skin layer. Ending inflammation too early would then leave a closed surface vulnerable to shear, a force that slides adjacent layers past one another.S2S4S9
Rests on: The preceding question supplies the possibility that inflammation timing should depend on matrix maturity, but it does not supply the proposed enzyme substitution. S2, in Biochemical and Biophysical Research Communications in 2023, states that myeloperoxidase can bind proteins in the material surrounding cells; that does not establish access to unfinished collagen IV or crosslink formation in healing skin. S4, in Antioxidants in 2022, describes peroxidasin-dependent collagen IV crosslinking, but does not establish that myeloperoxidase can perform it. S9, in Biochemical Society Transactions in 2023, reports laboratory studies in which cells made to produce peroxidasin generated collagen IV crosslinks whereas cells made to produce myeloperoxidase did not; those studies do not settle the proposed window during new membrane assembly in healing skin.
LeapThe missing bridge is a basis for assigning myeloperoxidase the crosslink-forming role specifically during early membrane assembly, despite the supplied report of failure in another laboratory setting. The gap concerns this particular enzyme substitution and access window, not the fact that the endpoint is an untested proposal.
What is carried, and what is not. The screened literature supports background components: S4, in Antioxidants in 2022, describes collagen IV crosslinking by peroxidasin, and S2, in Biochemical and Biophysical Research Communications in 2023, describes myeloperoxidase binding to surrounding structural proteins; neither establishes the proposed repair role in skin. No supplied source establishes the sequence end to end, and S9, in Biochemical Society Transactions in 2023, reports crosslink formation with peroxidasin but not myeloperoxidase in the laboratory setting it describes, providing contrary evidence without resolving the proposed new-assembly setting.S4S2S9
Where the reasoning is carried by something unstated · 2
- Goal pillar. It assumes that improving the coordination of wound repair and return to loading would advance the stated goal of restoring youthful function in middle-aged skin. The goal itself does not establish that connection.
- Hypothesis. The missing bridge is a basis for assigning myeloperoxidase the crosslink-forming role specifically during early membrane assembly, despite the supplied report of failure in another laboratory setting. The gap concerns this particular enzyme substitution and access window, not the fact that the endpoint is an untested proposal. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Loss of the benefit after disabling myeloperoxidase could be attributed to loss of direct crosslinking even if the intervention also changes immune-cell behavior or the signals controlling repair. What closes it: The design requires independent alteration of catalytic activity, the enzyme's ability to drive a chemical reaction, while preserving neutrophil numbers, the cytokine profile, the pattern of immune signaling proteins, and the duration of transforming growth factor beta signaling, a cell communication process involved in repair. Those conditions must be verified rather than inferred from the intervention's intended target.
- Stronger reconstructed skin could be credited to improved attachment between layers when the measured improvement actually comes from the dermis, the deeper supporting skin layer, or from recovery of the surface barrier. More crosslinks alone would also not establish faster functional recovery. What closes it: As the specification requires, strength of the deeper layer, strength of attachment between layers and barrier recovery must be measured separately. Crosslink abundance must be paired with the time to resistance against sliding forces, using a definition of recovery fixed before the comparison; the supplied material gives no threshold.
- Better healing after longer inflammation could reflect prevention of microbial regrowth rather than direct membrane construction. Equal current microbe counts would not exclude the rival explanation that the microbes differ in their ability to grow back. What closes it: The proposed skin model must be verified as sterile throughout the relevant comparison. The separate system without cells must establish bond formation and improved attachment after reaction chemicals are removed, with a matched preparation lacking active myeloperoxidase and a peroxidasin comparison to establish that the system can support crosslinking.
What would make this wrong. The proposed chain would fail if, in a working system that reproduces the specified new-membrane assembly window, peroxidasin forms the required collagen IV crosslinks but active myeloperoxidase does not. It would also fail if myeloperoxidase increases those crosslinks without improving attachment and shortening functional recovery. A negative result from disabling myeloperoxidase would remain ambiguous if the intervention also altered the other required features of inflammation.
What it would change. If the hypothesis held, ending inflammation would have to account for completion of structural attachment as well as control of microbes: surface closure alone would not mark readiness for renewed loading. For the master goal, this would identify a candidate way to improve repair under conditions of insufficient peroxidasin activity. It would still not establish that those conditions explain impaired function in middle-aged human skin, that prolonging inflammation is beneficial overall, or that this approach restores the broader functions of young skin.
Sources read · 10
Peroxidasin Inhibition by Phloroglucinol and Other Peroxidase Inhibitors. · Antioxidants (Basel, Switzerland) · 2023
“We have identified potent inhibitors of PXDN that may be useful leads for the design of compounds with greater specificity.”
Does not settle: This source text does not establish a neutrophil MPO role in healing skin, MPO access to uncrosslinked collagen IV, sulfilimine crosslink formation by MPO, effects of reduced peroxidasin activity, inflammation timing, mechanical epidermal attachment, or SPV_4 stabilization.
Mechanism of peroxidasin inactivation in hyperglycemia: Heme damage by reactive oxygen species. · Biochemical and biophysical research communications · 2023
“MPO and LPO are involved in protection from bacterial and parasite infection, and MPO can bind to ECM proteins [ , ].”
Does not settle: Источник не устанавливает, что миелопероксидаза создаёт сульфилиминовые сшивки коллагена IV, участвует в заживлении кожи или компенсирует недостаточность пероксидазина.
Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes. · Journal of the American Society of Nephrology : JASN · 2018
“Exposure of the cryptic epitope is thought to occur via disruption of sulfilimine crosslinks in the NC1 domain that are formed by peroxidasin-dependent production of hypobromous acid.”
Does not settle: Не устанавливает роль миелопероксидазы нейтрофилов в заживлении кожи, сшивании нового коллагена IV, механическом закреплении эпидермиса или SPV_4.
Halogenation Activity of Mammalian Heme Peroxidases. · Antioxidants (Basel, Switzerland) · 2022
“Whereas PXDN catalyzes the bromine-dependent formation of cross-links during the synthesis of collagen IV in connective tissues [ ], the physiological role of PXDNL remains unknown [ ].”
Does not settle: Источник не устанавливает, что миелопероксидаза нейтрофилов создаёт сульфилиминовые сшивки коллагена IV в заживающей коже, действует при недостаточности пероксидазина или влияет на механическую устойчивость эпидермиса и сроки функционального восстановления.
Fibronectin and wound healing. · Journal of cellular biochemistry · 1984
“At the level of matrix synthesis, fibronectin appears to be involved both in the organization of the granulation tissue and basement membrane.”
Does not settle: The source does not establish any role for neutrophil myeloperoxidase, peroxidasin, collagen IV sulfilimine crosslinks, basement-membrane maturation, epidermal mechanical anchoring, inflammation duration, or SPV_4.
Identification of tyrosine brominated extracellular matrix proteins in normal and fibrotic lung tissues. · Redox biology · 2024
“Peroxidasin (PXDN) is a secreted heme peroxidase that catalyzes the oxidative crosslinking of collagen IV within the extracellular matrix (ECM) via intermediate hypobromous acid (HOBr) synthesis from hydrogen peroxide and bromide, but recent findings have also suggested alternative ECM protein modifications by PXDN, including incorporation of bromide into tyrosine residues.”
Does not settle: Источник не исследует заживление кожи, позднюю нейтрофильную фазу, миелопероксидазу как фермент сшивания коллагена IV, компенсацию дефицита пероксидазина, механическое закрепление эпидермиса или сроки функционального восстановления.
Sulfilimine bond formation in collagen IV. · Chemical communications (Cambridge, England) · 2024
“The process involves the reaction of hypohalous acids (e.g., HOBr, HOCl), produced by a peroxidasin enzyme in the basement membrane, with the sidechain sulfur of methionine or sidechain nitrogen of lysine/hydroxylysine residues in collagen IV, to form halosulfonium or haloamine intermediates, respectively.”
Does not settle: This abstract does not establish any role for neutrophil myeloperoxidase, wound healing skin, late inflammation, peroxidasin deficiency, uncrosslinked collagen IV during repair, mechanical epidermal attachment, or SPV_4.
Obesity-driven changes in breast tissue exhibit a pro-angiogenic extracellular matrix signature. · Matrix biology plus · 2024
“Notably, the collagen IV crosslinking enzyme peroxidasin (PXDN) emerged as a potential mediator of the ECM changes in individuals with an elevated body mass index (BMI), strongly correlating with angiogenic and basement membrane signatures.”
Does not settle: This source does not examine healing skin, neutrophils or myeloperoxidase, sulfilimine crosslinks, incomplete collagen IV networks, peroxidasin deficiency, inflammation timing, epidermal attachment, mechanical resistance to shear, or SPV_4.
The role of peroxidasin in solid cancer progression. · Biochemical Society transactions · 2023
“in in vitro studies in which cells were transfected with PXDN, MPO and LPO cDNA and seeded onto uncross-linked basement membrane, only cells transfected with PXDN cDNA were able to generate collagen IV cross-links”
Does not settle: Источник не устанавливает роль нейтрофильной миелопероксидазы в заживлении кожи, поздней нейтрофильной фазе, механической прочности эпидермиса или последствиях преждевременного прекращения воспаления.
Activation and Inhibition of Human Matrix Metalloproteinase-9 (MMP9) by HOCl, Myeloperoxidase and Chloramines. · Antioxidants (Basel, Switzerland) · 2022
“These data indicate that HOCl-mediated oxidation and MMP-mediated ECM degradation are synergistic and interdependent.”
Does not settle: This source does not test healing skin, collagen IV sulfilimine crosslinking, basement-membrane assembly, peroxidasin deficiency, inflammation timing, mechanical epidermal attachment, or SPV_4.
The gap this hypothesis explains
Can ending inflammation later restore skin function sooner when timing follows remaining microbes and tissue framework maturity?
Original wording · exactly as the pipeline generated it
Может ли более позднее завершение воспаления сокращать общее время функционального заживления, если момент переключения определяется остаточной микробной нагрузкой и зрелостью матрикса?
What this question is asking
The question concerns whether inflammation that ends later could nevertheless allow damaged skin to regain its function sooner. It asks about choosing when inflammation ends according to the amount of microbes still present and how far the tissue’s supporting framework has developed. The relevant comparison is earlier versus later completion of inflammation, measuring the total time until function returns rather than simply whether new tissue forms. The question assumes that these two conditions can determine a meaningful switching point, but the supplied sources do not establish that assumption. Its stated context is middle-aged human skin, although restoring youthful skin function is not established as equivalent to healing a wound.
- Inflammation
- The body’s response to injury or harmful material. The question concerns how long this response continues during repair.
- Inflammation resolution
- The process through which inflammation subsides and ends. Calling this a switch is a simplification; the supplied sources do not establish one discrete switching event.
- Residual microbial burden
- The amount of microbes, meaning microscopic organisms, remaining in the affected tissue. Bacteria are one group of microbes; the supplied evidence provides no measurement or cutoff for using their remaining amount to determine timing.
- Matrix maturity
- How far the material surrounding and supporting tissue cells has developed into its repaired state. Maturity describes a degree of development, not an established yes-or-no condition, and the supplied material does not define how to measure it.
- Functional recovery or functional healing
- Recovery of the tissue’s ability to perform its functions. This differs from observing new tissue formation, and the question does not specify which skin function must return.
- Functional endpoint
- The specified functional result used to decide that recovery has occurred. Total recovery time cannot be interpreted consistently without defining this result.
- Tissue regeneration
- Formation or restoration of tissue during repair. Reports of faster regeneration do not by themselves establish faster recovery of function.
- Endotoxin
- A component of certain bacteria that can trigger inflammation. S6 states that it can impair wound healing; its presence is not itself a measure of how many microbes remain.
- Clearance of dying cells
- Removal of cells undergoing a controlled process of death. S1 connects this process with heart wound healing and inflammation resolution.
- Experimental model
- A studied system used to examine an injury or repair process. Findings in mouse liver injury or rat skin wounds do not establish the same result in middle-aged human skin.
The switching time for ending inflammation is determined by residual microbial burden and matrix maturity.
Residual microbial burden means the amount of microbes remaining in the affected tissue, while matrix maturity describes how far the material supporting its cells has developed. The question assumes that these two conditions can specify when inflammation should end. If established, that rule would distinguish a delay tied to tissue conditions from inflammation that merely persists.
The supplied sources do not establish a switching rule based on either condition, individually or together. S4 reports microbial defense, inflammation resolution and tissue regeneration occurring with treatment, but does not describe using microbial burden or matrix maturity to choose timing. S7 connects bacterial interference with prolonged inflammation, which supports relevance of microbes but does not establish the proposed rule. This absence from the supplied evidence does not show that the rule is false.S4S7
The same question asked without the part nothing read establishes:
- Does ending inflammation later rather than earlier shorten the time for skin function to recover at comparable levels of remaining microbes and tissue framework maturity?
- Does ending inflammation later rather than earlier shorten the total time for skin function to recover?
- Later completion shortens recovery Under the question’s proposed rule, inflammation would end later, yet skin would reach the same functional endpoint sooner. This would mean that time spent before inflammation ends cannot by itself indicate the total recovery time; the supplied evidence does not establish the intervening mechanism.
- Later completion lengthens recovery Under the proposed rule, delaying inflammation’s end would also delay the return of skin function. Treating that delay as beneficial would therefore prolong the outcome the rule was intended to shorten.
- Later completion leaves recovery unchanged Inflammation would end at different times, but skin would reach the same functional endpoint at the same time. Changing this timing would then provide no demonstrated reduction in overall recovery time under the compared conditions.
The proposed sequence connects remaining microbes and tissue framework maturity to the timing of inflammation’s end, and that timing to the duration of functional recovery. The supplied literature reports that bacteria can interfere with repair by prolonging inflammation, while another source links clearance of dying cells to inflammation ending and heart function recovering (S7, S1). These findings make the reason inflammation persists relevant to interpreting its duration; that connection is an inference, not a tested timing rule. Assuming that a longer inflammatory period helps could mistake an obstacle to healing for a useful delay. Assuming that faster tissue formation proves faster functional recovery could also assign a benefit that the supplied evidence has not measured.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Поздняя нейтрофильная фаза может непосредственно завершать химическое созревание новой базальной мембраны. Гипотеза предполагает, что в заживающей коже миелопероксидаза нейтрофилов получает доступ к ещё не включённым в плотную сеть участкам коллагена IV и создаёт сульфилиминовые сшивки до завершения сборки мембраны. При недостаточной активности пероксидазина этот временный путь становится необходимым для механического закрепления эпидермиса. Преждевременное прекращение воспаления оставляет поверхность закрытой, но уязвимой к сдвигу; ограниченное продление воспаления сокращает время до устойчивого функционального восстановления. Физический носитель незавершённого состояния представляет собой несшитый коллаген IV. Завершение его созревания стабилизирует SPV_4.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
В стерильной модели кожи с недостаточным пероксидазином поздняя нейтрофильная фаза увеличит количество сульфилиминовых сшивок и сократит время до устойчивости к сдвигу. Выключение каталитической активности миелопероксидазы устранит этот выигрыш при сохранённых числе нейтрофилов, цитокиновом профиле и длительности TGF-β-сигнала. Решающий результат: бесклеточная система сборки новой базальной мембраны воспроизведёт образование сшивок под действием миелопероксидазы, а полученная мембрана после удаления реагентов улучшит механическое закрепление эпидермиса. Если сшивки образует только пероксидазин или рост их количества не улучшает функциональное восстановление, гипотеза отвергается.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable changes in crosslink abundance and mechanical recovery, loss of benefit upon catalytic inactivation under stated controls, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Отдельные звенья можно проверить на очищенном коллагене IV, бесклеточных матрицах и реконструированной коже с иммунными клетками. Самое трудное условие состоит в независимом изменении катализа миелопероксидазы при сохранении остальных свойств воспаления. Прочность дермы, прочность соединения слоёв и восстановление барьера необходимо измерять отдельно.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
В стерильной модели кожи с недостаточным пероксидазином поздняя нейтрофильная фаза увеличит количество сульфилиминовых сшивок и сократит время до устойчивости к сдвигу. Выключение каталитической активности миелопероксидазы устранит этот выигрыш при сохранённых числе нейтрофилов, цитокиновом профиле и длительности TGF-β-сигнала. Решающий результат: бесклеточная система сборки новой базальной мембраны воспроизведёт образование сшивок под действием миелопероксидазы, а полученная мембрана после удаления реагентов улучшит механическое закрепление эпидермиса. Если сшивки образует только пероксидазин или рост их количества не улучшает функциональное восстановление, гипотеза отвергается.
- Rival 01 of 02What would separate them
Longer inflammation may speed healing by damaging both strands of bacterial genetic material predicts: При одинаковых жизнеспособной микробной нагрузке, общем количестве повреждений ДНК и зрелости матрикса позднее завершение воспаления даст преимущество преимущественно в образцах с большим числом пространственно сопряжённых повреждений противоположных цепей. Их частота должна предсказывать утрату способности отдельных бактерий давать потомство и последующее отсутствие воспалительного рецидива лучше, чем суммарное окислительное повреждение. В стерильных образцах преимущество исчезнет. Если различия определяются только числом живых бактерий, а геометрия повреждений после учёта этого числа ничего не предсказывает, предложенный механизм отвергается.
- Rival 02 of 02What would separate them
Conflating immune suppression with active resolution may explain an apparent benefit of delay predicts: В факторном сравнении раннего и позднего начала двух типов вмешательства преимущество позднего срока обнаружится для подавления иммунных эффекторных функций, но исчезнет для активного разрешения, сохраняющего противомикробную активность. При сопоставимых исходной зрелости матрикса, длительности TGF-β-сигнала и фактическом воздействии на мишень раннее активное разрешение обеспечит такое же или меньшее время до одновременного восстановления барьера, устойчивости к нагрузке и микробного контроля. Наличие воспроизводимого преимущества позднего срока при сохранённых защитных функциях опровергнет эту гипотезу.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
Парадоксальное наблюдение: миелопероксидаза образовывала сульфилиминовые сшивки в растворимых фрагментах коллагена IV, но не сшивала нативную базальную мембрану даже при высокой ферментативной активности. Гипотеза переносит эту химическую возможность на короткое окно сборки новой мембраны. Результат на нативной мембране является существенным контраргументом, который эксперимент должен преодолеть. [Bhave et al., 2012](https://pmc.ncbi.nlm.nih.gov/articles/PMC4128002/).
Биология базальных мембран и репаративная дерматология. Пересмотра потребует учебная глава «Сборка и ковалентное созревание сети коллагена IV»: предполагается физиологически значимый обход пероксидазина воспалительной пероксидазой именно при восстановлении ткани.
Нейтрофильный окислительный фермент восстановит механически полезные сшивки новой базальной мембраны при выключенном пероксидазине, причём эффект сохранится после удаления воспалительных клеток и реагентов.
В проверенных источниках не найдено утверждения, что миелопероксидаза физиологически заменяет пероксидазин при восстановлении базальной мембраны кожи. Напротив, экспериментальные данные поддерживают особую роль пероксидазина в сшивании нативной сети. Это ограниченная проверка новизны; отсутствие такой гипотезы во всей литературе не доказано. [Исследование доменов пероксидазина](https://pmc.ncbi.nlm.nih.gov/articles/PMC4571896/).
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.